CXCL10 and cutaneous mastocytosis: Our previous studies indicate that the potent anti-angiogenic and apoptotic factor, CXCL10, is remarkably elevated in plasma/serum and cerebrospinal fluid of patients who died from CM compared to those who survive the disease after treatment confirming the association between elevated CXCL10 in CM patients with poor prognosis [15]–[17].